20/20 Biolabs, Inc. (AIDX) › Weighted Average Diluted Shares20/20 Biolabs, Inc. (AIDX): Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.4.93MYear ended 2025-12-312024-12-31: 4.80M2025-12-31: 4.93M4.93M2024-12-31 Weighted Average Diluted Shares (shares) 2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-314.93M+2.7%2026-03-31, From 2025-01-012024-12-314.80Mn/a2026-03-31, From 2024-01-01Other metrics: RevenueCost of RevenueGross ProfitR&D ExpenseOperating IncomeDepreciation & AmortizationEBITDANet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingEPS (Basic)